title: Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel .
abstract: Prior X-ray crystal structures of rabbit cytochrome P450 2B4 (2B4) in complexes with various imidazoles have demonstrated markedly different enzyme conformations depending on the size of the inhibitor occupying the active site. In this study, structures of 2B4 were determined with the antiplatelet drugs clopidogrel and ticlopidine, which were expected to have greater freedom of movement in the binding pocket. Ticlopidine could be modeled into the electron density maps in two distinct orientations, both of which are consistent with metabolic data gathered with other mammalian P450 enzymes. Results of ligand docking and heme-induced NMR relaxation of drug protons showed that ticlopidine was preferentially oriented with the chlorophenyl group closest to the heme. Because of its stereocenter, clopidogrel was easier to fit in the electron density and exhibited a single orientation, which points the chlorophenyl ring toward the heme. The C(α) traces of both complexes aligned very well with each other and revealed a compact, closed structure that resembles the conformation observed in two previously determined 2B4 structures with the small molecule inhibitors 4-(4-chlorophenyl)imidazole and 1-(4-chlorophenyl)imidazole. The 2B4 active site is able to accommodate small ligands by moving only a small number of side chains, suggesting that ligand reorientation is energetically favored over protein conformational changes for binding of these similarly sized molecules. Adjusting both protein conformation and ligand orientation in the active site gives 2B4 the flexibility to bind to the widest range of molecules, while also being energetically favorable.
authors.affiliation: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, USA. scgay@ucsd.edu
authors.forename: Sean C
authors.initials: SC
authors.lastname: Gay
authors.forename: Arthur G
authors.initials: AG
authors.lastname: Roberts
authors.forename: Keiko
authors.initials: K
authors.lastname: Maekawa
authors.forename: Jyothi C
authors.initials: JC
authors.lastname: Talakad
authors.forename: Wen-Xu
authors.initials: WX
authors.lastname: Hong
authors.forename: Qinghai
authors.initials: Q
authors.lastname: Zhang
authors.forename: C David
authors.initials: CD
authors.lastname: Stout
authors.forename: James R
authors.initials: JR
authors.lastname: Halpert
mesh_terms: D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism*; D000077144:Clopidogrel; D018360:Crystallography, X-Ray; D000072467:Cytochrome P450 Family 2; D008958:Models, Molecular; D019906:Nuclear Magnetic Resonance, Biomolecular; D010975:Platelet Aggregation Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D011485:Protein Binding; D011817:Rabbits; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; D000072467:Cytochrome P450 Family 2; C465241:cytochrome P-450 CYP2B4 (rabbit); D013988:Ticlopidine
references.citation: Br J Pharmacol. 2004 Jun;142(3):551-7
references.pmid: 15148251
references.citation: Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
references.pmid: 15299926
references.citation: Biochemistry. 2005 Nov 1;44(43):14143-51
references.pmid: 16245930
references.citation: Curr Drug Metab. 2007 Jun;8(5):407-47
references.pmid: 17584015
references.citation: Drug Metab Dispos. 2010 Jan;38(1):92-9
references.pmid: 19812348
references.citation: Drug Metab Dispos. 2004 Jan;32(1):49-57
references.pmid: 14709620
references.citation: Biochemistry. 2004 Jun 8;43(22):7207-14
references.pmid: 15170358
references.citation: Methods Enzymol. 1989;177:403-13
references.pmid: 2575205
references.citation: Biochim Biophys Acta. 2007 Mar;1770(3):376-89
references.pmid: 17069978
references.citation: J Comput Chem. 2005 Dec;26(16):1701-18
references.pmid: 16211538
references.citation: Ann Intern Med. 1998 Sep 1;129(5):394-405
references.pmid: 9735068
references.citation: J Clin Pharmacol. 2010 Feb;50(2):126-42
references.pmid: 19948947
references.citation: Eur Biophys J. 2005 Jun;34(4):273-84
references.pmid: 15803330
references.citation: Methods Enzymol. 1997;276:344-58
references.pmid: 9048378
references.citation: Plant Physiol. 2003 Nov;133(3):1198-208
references.pmid: 14576280
references.citation: J Magn Reson. 2000 Jan;142(1):57-63
references.pmid: 10617435
references.citation: Biophys J. 2001 Sep;81(3):1275-84
references.pmid: 11509344
references.citation: J Magn Reson. 2002 Nov;159(1):76-81
references.pmid: 12468306
references.citation: Chem Res Toxicol. 2007 Oct;20(10):1434-41
references.pmid: 17894464
references.citation: Biochemistry. 2009 Jun 9;48(22):4762-71
references.pmid: 19397311
references.citation: Structure. 1997 Mar 15;5(3):325-36
references.pmid: 9083112
references.citation: Drug Metab Dispos. 2009 Mar;37(3):589-93
references.pmid: 19047469
references.citation: Drug Metab Dispos. 2009 Sep;37(9):1904-15
references.pmid: 19541827
references.citation: Clin Pharmacol Ther. 1997 Nov;62(5):572-7
references.pmid: 9390115
references.citation: Chem Rev. 2009 Sep;109(9):4108-39
references.pmid: 19522502
references.citation: Arch Biochem Biophys. 1995 Jul 10;320(2):330-44
references.pmid: 7625841
references.citation: J Med Chem. 2006 Nov 30;49(24):6987-7001
references.pmid: 17125252
references.citation: Drug Metab Pharmacokinet. 2008;23(6):412-20
references.pmid: 19122335
references.citation: Eur J Drug Metab Pharmacokinet. 1981;6(2):91-8
references.pmid: 7274310
references.citation: Angew Chem Int Ed Engl. 2007;46(37):7023-5
references.pmid: 17691085
references.citation: J Pharm Biomed Anal. 1998 Jul;17(3):419-25
references.pmid: 9656153
references.citation: Chem Res Toxicol. 2010 May 17;23(5):909-17
references.pmid: 20297803
references.citation: Mol Pharmacol. 2010 Apr;77(4):529-38
references.pmid: 20061448
references.citation: NMR Biomed. 2001 Jun;14(4):271-7
references.pmid: 11410945
references.citation: Acta Crystallogr D Biol Crystallogr. 1999 Oct;55(Pt 10):1696-702
references.pmid: 10531519
references.citation: Methods Mol Biol. 2008;426:145-59
references.pmid: 18542861
references.citation: NMR Biomed. 1996 May;9(3):93-104
references.pmid: 8892395
references.citation: J Pharmacol Exp Ther. 2004 Jan;308(1):189-97
references.pmid: 14563790
references.citation: Protein Eng. 1990 Dec;4(2):177-84
references.pmid: 2075193
references.citation: Biochim Biophys Acta. 2007 Mar;1770(3):402-12
references.pmid: 16935426
references.citation: Biochemistry. 2007 Jan 9;46(1):106-19
references.pmid: 17198380
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
references.pmid: 20383002
references.citation: Biophys Chem. 2006 Sep 20;123(2-3):95-101
references.pmid: 16701937
references.citation: Biochemistry. 2007 Oct 16;46(41):11559-67
references.pmid: 17887776
references.citation: Biophys J. 1995 Sep;69(3):810-24
references.pmid: 8519982
references.citation: Biochemistry. 1997 Apr 15;36(15):4461-70
references.pmid: 9109653
references.citation: J Biomol NMR. 1992 Nov;2(6):661-5
references.pmid: 1490109
references.citation: Agents Actions Suppl. 1984;15:68-75
references.pmid: 6385655
references.citation: Nat Struct Mol Biol. 2005 Sep;12(9):822-3
references.pmid: 16086027
references.citation: Drug Metab Dispos. 2004 Jun;32(6):626-31
references.pmid: 15155554
references.citation: Curr Drug Metab. 2001 Jun;2(2):117-37
references.pmid: 11469721
references.citation: J Biol Chem. 2004 Jun 25;279(26):27294-301
references.pmid: 15100217
references.citation: Magn Reson Med. 2000 Oct;44(4):646-9
references.pmid: 11025522
references.citation: J Biol Chem. 2006 Mar 3;281(9):5973-81
references.pmid: 16373351
references.citation: J Biol Chem. 2006 Mar 24;281(12):8051-61
references.pmid: 16439365
references.citation: Biochem Biophys Res Commun. 2005 Dec 9;338(1):331-6
references.pmid: 16157296
references.citation: Biochemistry. 2001 Oct 9;40(40):12112-22
references.pmid: 11580286
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13196-201
references.pmid: 14563924
references.citation: Biochemistry. 1995 Jul 18;34(28):8982-8
references.pmid: 7619797
references.citation: Acta Crystallogr D Biol Crystallogr. 2003 Jul;59(Pt 7):1124-30
references.pmid: 12832754
references.citation: J Am Chem Soc. 2004 May 12;126(18):5879-96
references.pmid: 15125681
references.citation: J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
references.pmid: 19461840
references.citation: Arch Biochem Biophys. 2000 Dec 1;384(1):47-58
references.pmid: 11147835
references.citation: Biochemistry. 1996 Apr 9;35(14):4540-50
references.pmid: 8605204
references.citation: Acta Crystallogr D Biol Crystallogr. 1994 Mar 1;50(Pt 2):178-85
references.pmid: 15299456
references.citation: Br J Clin Pharmacol. 1999 Apr;47(4):454-7
references.pmid: 10233213
references.citation: Acta Crystallogr A. 2008 Sep;64(Pt 5):519-28
references.pmid: 18708715
references.citation: Magn Reson Med. 1997 May;37(5):651-7
references.pmid: 9126938